Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has informed the stock exchanges that the trading window for its designated persons will be closed from January 01, 2026, until 48 hours after the announcement of unaudited financial results for the quarter ended December 31, 2025. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015, and signals that the company is approaching the declaration of its Q3 FY26 earnings. The date of the board meeting to approve these results has not yet been disclosed and will be communicated separately. Ms. Dimpy Joshi, Company Secretary & Compliance Officer, has signed the filing.
This is a routine regulatory filing with no direct impact on shareholders. However, it indicates that the company's Q3 FY26 results are likely due in the coming weeks, which investors should watch for as it could influence the stock price.